Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2023. Go to the latest filing (Q3 2026)

21.2B USDQ1 2023
Total value of stock positions
21.2B USD
Positions
80
Share of the ten largest
43.1%

The ten largest positions Q1 2023

  1. Visa Inc. 7.0%▲ +13.4%
  2. McKesson Corporation 5.4%▲ +45.5%
  3. UnitedHealth Group 4.7%▲ +65.7%
  4. Elevance Health 4.7%▲ +15.1%
  5. GE Aerospace 3.9%▲ +10.8%
  6. Fortinet 3.7%▲ +66.6%
  7. Amazon 3.7%▼ −38.9%
  8. Api Group Corp 3.6%▲ +0.8%
  9. Lululemon Athletica 3.2%new
  10. Meta Platforms 3.2%▲ +35.3%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q1 2023

Positions Q1 2023 per 13F filing, 50 of 80
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 3.7% 7,628,220 787.9M USD −38.9% reduced Q2 2015 32 quarters
MSFT Microsoft 1.4% 1,047,352 302.0M USD −69.5% reduced Q2 2016 28 quarters
V Visa Inc. 7.0% 6,560,069 1.5B USD +13.4% increased Q3 2016 27 quarters
Catalent Inc 0.4% 1,201,210 78.9M USD −15.7% reduced Q1 2018 21 quarters
BSX Boston Scientific 0.3% 1,136,881 56.9M USD −88.1% reduced Q3 2018 19 quarters
Bridgebio Pharma Inc 2.1% 26,620,991 441.4M USD unchanged Q2 2019 16 quarters
Adaptive Biotechnologies Cor 1.2% 29,993,708 264.8M USD unchanged Q2 2019 16 quarters
FTV Fortive 2.0% 6,346,528 432.6M USD +63.1% increased Q3 2019 15 quarters
Molina Healthcare Inc 0.7% 594,553 159.0M USD +1.1% increased Q3 2019 15 quarters
Guardant Health Inc 0.3% 2,538,889 59.5M USD −38.2% reduced Q3 2019 15 quarters
CB Chubb Limited 3.2% 3,466,740 673.2M USD −3.2% reduced Q1 2020 13 quarters
Api Group Corp 3.6% 34,090,285 766.3M USD +0.8% increased Q2 2020 12 quarters
TMO Thermo Fisher Scientific 2.3% 856,836 493.9M USD +2.1% increased Q2 2020 12 quarters
Royalty Pharma PLC 1.9% 11,204,249 403.7M USD +11.9% increased Q2 2020 12 quarters
Karuna Therapeutics Inc 1.3% 1,501,074 272.7M USD +26.8% increased Q3 2020 11 quarters
Inhibrx Inc 0.6% 6,639,199 125.3M USD unchanged Q3 2020 11 quarters
GE GE Aerospace 3.9% 8,612,232 823.3M USD +10.8% increased Q4 2020 10 quarters
META Meta Platforms 3.2% 3,229,914 684.5M USD +35.3% increased Q4 2020 10 quarters
Acadia Healthcare Company In 1.1% 3,354,110 242.3M USD +6.1% increased Q4 2020 10 quarters
4D Molecular Therapeutics In 0.3% 3,937,914 67.7M USD unchanged Q4 2020 10 quarters
Kinnate Biopharma Inc < 0.1% 1,820,462 11.4M USD unchanged Q4 2020 10 quarters
AMP Ameriprise Financial 1.4% 941,040 288.4M USD −42.9% reduced Q1 2021 9 quarters
CRL Charles River Laboratories 0.4% 394,089 79.5M USD −23.5% reduced Q1 2021 9 quarters
Zai Lab Ltd 0.4% 2,331,245 77.5M USD +18.1% increased Q1 2021 9 quarters
Edgewise Therapeutics Inc 0.2% 4,909,146 32.7M USD +11.3% increased Q1 2021 9 quarters
Pharvaris N V 0.1% 3,231,923 25.3M USD unchanged Q1 2021 9 quarters
Intellia Therapeutics Inc 0.3% 1,569,545 58.5M USD −22.4% reduced Q2 2021 8 quarters
Day One Biopharmaceuticals I < 0.1% 1,558,563 20.8M USD unchanged Q2 2021 8 quarters
Talaris Therapeutics Inc < 0.1% 3,289,617 6.2M USD unchanged Q2 2021 8 quarters
Hdfc Bank Ltd 2.6% 8,285,627 552.4M USD −3.3% reduced Q3 2021 7 quarters
Ginkgo Bioworks Holdings Inc 0.9% 143,085,126 190.3M USD +126.8% increased Q3 2021 7 quarters
Rallybio Corp 0.1% 4,194,777 24.0M USD unchanged Q3 2021 7 quarters
Roivant Sciences Ltd 3.1% 88,238,700 651.2M USD unchanged Q4 2021 6 quarters
Biomarin Pharmaceutical Inc 1.0% 2,168,617 210.9M USD −58.9% reduced Q4 2021 6 quarters
XYZ Block, Inc. 0.8% 2,354,123 161.6M USD −47.5% reduced Q4 2021 6 quarters
IFF International Flavors & Fragrances 0.4% 812,680 74.7M USD +85.0% increased Q4 2021 6 quarters
Lianbio < 0.1% 3,564,173 7.0M USD unchanged Q4 2021 6 quarters
ELV Elevance Health 4.7% 2,154,556 990.7M USD +15.1% increased Q1 2022 5 quarters
MA Mastercard 1.4% 796,740 289.5M USD −53.4% reduced Q1 2022 5 quarters
Unum Group 0.8% 4,253,413 168.3M USD +24.0% increased Q1 2022 5 quarters
PGR Progressive Corporation 0.7% 1,003,562 143.6M USD +197.9% increased Q1 2022 5 quarters
Amylyx Pharmaceuticals Inc 0.4% 2,962,555 86.9M USD −36.1% reduced Q1 2022 5 quarters
Inspire Med Sys Inc 0.4% 346,576 81.1M USD −37.0% reduced Q1 2022 5 quarters
MCK McKesson Corporation 5.4% 3,207,080 1.1B USD +45.5% increased Q2 2022 4 quarters
INTU Intuit 2.6% 1,221,094 544.4M USD +3.3% increased Q2 2022 4 quarters
MU Micron Technology 0.8% 2,856,599 172.4M USD −65.8% reduced Q2 2022 4 quarters
Pepgen Inc < 0.1% 1,544,631 18.9M USD unchanged Q2 2022 4 quarters
Verastem Inc < 0.1% 9,224,000 3.8M USD unchanged Q2 2022 4 quarters
UNH UnitedHealth Group 4.7% 2,099,991 992.4M USD +65.7% increased Q3 2022 3 quarters
Valvoline Inc 1.2% 7,398,713 258.5M USD +51.7% increased Q3 2022 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 80 positions.

Plus 1 position in convertible bonds and bonds worth 81.0M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 81.0M USD

Breakdown by sector

  • Health Care 17.7%
  • Financials 14.8%
  • Technology 11.2%
  • Industrials 10.0%
  • Consumer Discretionary 7.5%
  • Communication Services 3.2%
  • Materials 2.7%
  • Utilities 0.8%
  • Consumer Staples 0.2%
  • not in our coverage 31.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close